CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-15 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −12,101 | $78.27 | $947K | 146,012 |
| 2022-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award · Stock Option (Right to buy Common Stock) | +35,830 | 35,830 | ||
| 2022-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +11,040 | 40,749 | ||
| 2022-03-15 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −1,868 | $78.27 | $146K | 38,881 |
| 2022-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +26,520 | 26,520 | ||
| 2022-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +11,040 | 52,976 | ||
| 2022-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Shares withheld for taxes | −920 | $78.27 | $72K | 52,056 |
| 2022-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to buy Common Stock) | +26,520 | 26,520 | ||
| 2022-03-15 | Davis George Eric EVP, General Counsel | Grant or award | +11,040 | 79,000 | ||
| 2022-03-15 | Davis George Eric EVP, General Counsel | Shares withheld for taxes | −8,290 | $78.27 | $649K | 70,710 |
| 2022-03-15 | Davis George Eric EVP, General Counsel | Grant or award · Stock Option (Right to buy Common Stock) | +26,520 | 26,520 | ||
| 2022-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award | +40,280 | 378,849 | ||
| 2022-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −38,306 | $78.27 | $3.0M | 340,543 |
| 2022-03-15 | BIENAIME JEAN JACQUES Chief Executive Officer | Grant or award · Stock Option (Right to buy Common Stock) | +58,040 | 58,040 | ||
| 2022-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +11,940 | 77,163 | ||
| 2022-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −8,418 | $78.27 | $659K | 68,745 |
| 2022-03-15 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +28,670 | 28,670 | ||
| 2022-03-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +15,000 | $37.46 | $562K | 353,569 |
| 2022-03-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −15,000 | $77.81 | $1.2M | 338,569 |
| 2022-03-11 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −15,000 | 85,000 |
Page 25 of 36 · 707 trades